- CPHIA 2025 meets in Durban this week.
- The meeting opened on Tuesday.
- Delegates from more than 20 countries attend.
- The African Union Commission, WHO and UNICEF attend.
- Gavi and the Global Fund also attend.
- Blade Nzimande speaks about a new vaccine plan.
- The plan has a US$3.2 billion investment.
- The plan aims for 60% local vaccine production by 2040.
- Speakers warn about cuts in aid spending.
- The conference will close on Saturday 25 October.
Difficult words
- leader — A person who guides or directs a group.leaders
- meet — To come together for a discussion or event.meeting
- problem — A difficulty or challenge that needs to be solved.problems
- chance — An opportunity or possibility.chances
- job — A position of employment or work.jobs
- vaccine — A substance to help prevent disease.vaccines
- produce — To make or create something.production
- important — Having great significance or value.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why do you think local vaccine production is important?
- What problems do you think leaders should focus on?
- How can turning problems into chances help communities?
Related articles
Turning Water Hyacinth into Biodegradable Sanitary Pads
Researcher Pooja Singh and colleagues used invasive water hyacinth to make eco-friendly sanitary pads. Their project won an Elsevier award in Pune and aims to reduce water and plastic pollution while supporting women in local communities.
Wheat fiber protects mice from intestinal inflammation
Two research papers report that adding wheat fiber to the diet protects mice from intestinal inflammation. Gut bacteria release polyphenols from the fiber that reduce inflammation, and authors suggest whole-grain foods may lower IBD risk.
Biodegradable patch may help heart heal after heart attack
Researchers report a biodegradable microneedle patch that delivers interleukin-4 to injured heart tissue. The local treatment encourages healing immune cells, reduces scarring, and may improve heart recovery while avoiding systemic side effects.
Experimental vaccine gives lasting protection in mice against CCHF
A new mouse study reports an experimental vaccine that produced rapid protection and antibodies that lasted up to 18 months. Researchers say a booster strengthened and extended immune responses and plan manufacturing steps before human trials.